Literature DB >> 23098492

Trends in the incidence of 15 common cancers in Hong Kong, 1983-2008.

Wen-Chuan Xie1, Man-Him Chan, Kei-Choi Mak, Wai-Tin Chan, Miao He.   

Abstract

BACKGROUND: The objective of this study WAS to describe cancer incidence rates and trends among THE Hong Kong population for the period 1983-2008.
METHODS: Incident cases and population data from 1983 to 2008 were obtained from the Hong Kong Cancer Registry and the Census and Statistics Department, respectively. Age- standardized incidence rates (ASIR) were estimated and joinpoint regression was applied to detect significant changes in cancer morbidity.
RESULTS: For all cancers combined, the ASIR showed declining trends (1.37% in men, 0.94% in women), this also being the case for cancers of lung, liver, nasopharynx, stomach, bladder, oesophagus for both genders and cervix cancer for women. With cancer of thyroid, prostate, male colorectal, corpus uteri, ovary and female breast cancer an increase was evident throughout the period. The incidence for leukemia showed a stable trend since early 1990 s, following an earlier decrease.
CONCLUSIONS: Although overall cancer incidence rates and certain cancers showed declining trends, incidence trends for colorectal, thyroid and sex-related cancers continue to rise. These trends in cancer morbidity can be used as an important resource to plan and develop effective programs aimed at the control and prevention of the spread of cancer amongst the Hong Kong population. It is particularly useful in allowing projection of future burdens on the society with the increase in certain cancer incidences.

Entities:  

Mesh:

Year:  2012        PMID: 23098492     DOI: 10.7314/apjcp.2012.13.8.3911

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  Prediction of central lymph node metastasis in 392 patients with cervical lymph node-negative papillary thyroid carcinoma in Eastern China.

Authors:  Yingying Xiang; Kuailu Lin; Siyang Dong; L I Qiao; Qiuxiang He; Xiaohua Zhang
Journal:  Oncol Lett       Date:  2015-07-29       Impact factor: 2.967

Review 2.  Prostate cancer in Asian men.

Authors:  Kazuto Ito
Journal:  Nat Rev Urol       Date:  2014-03-04       Impact factor: 14.432

3.  Time trends and age-period-cohort analyses on incidence rates of thyroid cancer in Shanghai and Hong Kong.

Authors:  Shao-Hua Xie; Juan Chen; Bo Zhang; Feng Wang; Shan-Shan Li; Chang-Hui Xie; Lap-Ah Tse; Jin-Quan Cheng
Journal:  BMC Cancer       Date:  2014-12-18       Impact factor: 4.430

Review 4.  Managing the changing burden of cancer in Asia.

Authors:  Rengaswamy Sankaranarayanan; Kunnambath Ramadas; You-lin Qiao
Journal:  BMC Med       Date:  2014-01-08       Impact factor: 8.775

5.  Androgen deprivation therapy and fracture risk in Chinese patients with prostate carcinoma.

Authors:  Chi-Ho Lee; Gang Huang; Pak-Hei Chan; Jojo Hai; Chun-Yip Yeung; Carol Ho-Yi Fong; Yu-Cho Woo; Kwan Lun Ho; Ming-Kwong Yiu; Frankie Leung; Tak-Wing Lau; Hung-Fat Tse; Karen Siu-Ling Lam; Chung-Wah Siu
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

6.  Patterns of Life Lost to Cancers with High Risk of Death in China.

Authors:  Yizhong Yan; Yu Chen; Huaimiao Jia; Jiaming Liu; Yusong Ding; Haixia Wang; Yunhua Hu; Jiaolong Ma; Xianghui Zhang; Shugang Li
Journal:  Int J Environ Res Public Health       Date:  2019-06-19       Impact factor: 3.390

7.  The performance of three-sample qualitative immunochemical fecal test to detect colorectal adenoma and cancer in gastrointestinal outpatients: an observational study.

Authors:  Dong Wu; Han-Qing Luo; Wei-Xun Zhou; Jia-Ming Qian; Jing-Nan Li
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

8.  Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China.

Authors:  Lingbin Du; Youqing Wang; Xiaohui Sun; Huizhang Li; Xinwei Geng; Minghua Ge; Yimin Zhu
Journal:  BMC Cancer       Date:  2018-03-15       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.